ZA9610770B - Osteoprotegerin. - Google Patents

Osteoprotegerin.

Info

Publication number
ZA9610770B
ZA9610770B ZA9610770A ZA9610770A ZA9610770B ZA 9610770 B ZA9610770 B ZA 9610770B ZA 9610770 A ZA9610770 A ZA 9610770A ZA 9610770 A ZA9610770 A ZA 9610770A ZA 9610770 B ZA9610770 B ZA 9610770B
Authority
ZA
South Africa
Prior art keywords
osteoprotegerin
Prior art date
Application number
ZA9610770A
Inventor
William J Boyle
Frank J Calzone
David L Lacey
Ming-Shi Chang
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of ZA9610770B publication Critical patent/ZA9610770B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9610770A 1995-12-22 1996-12-20 Osteoprotegerin. ZA9610770B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/577,788 US6613544B1 (en) 1995-12-22 1995-12-22 Osteoprotegerin

Publications (1)

Publication Number Publication Date
ZA9610770B true ZA9610770B (en) 1998-06-22

Family

ID=24310170

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9610770A ZA9610770B (en) 1995-12-22 1996-12-20 Osteoprotegerin.

Country Status (4)

Country Link
US (6) US6613544B1 (en)
DE (1) DE69637695D1 (en)
IL (1) IL205233A0 (en)
ZA (1) ZA9610770B (en)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919434B1 (en) 1995-02-20 2005-07-19 Sankyo Co., Ltd. Monoclonal antibodies that bind OCIF
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US7078493B1 (en) 1995-03-15 2006-07-18 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor-like genes
US20030207827A1 (en) * 1995-12-22 2003-11-06 William J. Boyle Osteoprotegerin
US7632922B1 (en) * 1995-12-22 2009-12-15 Amgen, Inc. Osteoprotegerin
US20050147611A1 (en) * 1995-12-22 2005-07-07 Amgen Inc. Combination therapy for conditions leading to bone loss
US7005413B1 (en) * 1995-12-22 2006-02-28 Amgen Inc. Combination therapy for conditions leading to bone loss
EP1803816A3 (en) * 1996-12-13 2007-09-26 Schering Corporation Mammalian cell surface antigens; related reagents
JP2002509431A (en) * 1996-12-23 2002-03-26 イミュネックス・コーポレーション NF-κB receptor activator-receptor is a member of the TNF receptor superfamily
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
RU2238949C2 (en) * 1997-04-15 2004-10-27 Санкио Компани Лимитед Protein binding specifically with osteoclastogenesis-inhibiting factor (ocif) (variants), dna encoding its (variants), dna as probe (variants), method for preparing protein (variants), method for screening substance (variants), antibody (variants), method for preparing polyclonal antibody, hybridoma (variants), method for preparing monoclonal antibody, method for assay of ocif-binding protein, pharmaceutical composition (variants) and medicinal agent (variants)
US6316408B1 (en) * 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
CZ302262B6 (en) 1997-04-16 2011-01-19 Amgen Inc. Isolated nucleic acid, polypeptide encoded by the nucleic acid, expression vector comprising the nucleic acid, host cell transformed or transfected with the expression vector, isolated osteoprotegerin binding protein, antibody, which specifically bin
US20030092002A1 (en) * 1997-09-17 2003-05-15 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2269114A1 (en) * 1997-09-24 1999-03-24 Snow Brand Milk Products Co., Ltd. Method for diagnosis of metabolic bone diseases
US20020184655A1 (en) * 1997-12-01 2002-12-05 Henryk Lubon Methods for the degradation and detoxification of organic material using urine produced by transgenic animals and related transgenic animals and proteins
EP2009025B1 (en) * 1998-05-14 2011-07-27 Immunex Corporation Method of inhibiting osteoclast activity
US20030078211A1 (en) * 1998-06-24 2003-04-24 Merck & Co., Inc. Compositions and methods for inhibiting bone resorption
AU757104B2 (en) 1998-06-24 2003-01-30 Merck & Co., Inc. Compositions and methods for inhibiting bone resorption
CA2347107A1 (en) * 1998-10-28 2000-05-04 Shinichi Mochizuki Bone-pathobolism treating agent
CA2369384A1 (en) * 1999-04-12 2000-10-19 Agensys, Inc. Prostate-restricted gene 30p3c8 expressed in prostate cancer
EP1140136B1 (en) * 1999-09-03 2007-05-16 Amgen Inc. Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
EP1238077A1 (en) * 1999-12-16 2002-09-11 Amgen Inc., Tnfr/opg-like molecules and uses thereof
US20030103978A1 (en) * 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
ES2208145T3 (en) * 2000-09-22 2007-12-16 Immunex Corporation SELECTION TESTS FOR AGONISTS OR ANTAGONISTS OF THE NF-KB ACTIVATOR RECEIVER.
US20040132971A1 (en) * 2001-02-09 2004-07-08 Haaning Jesper Mortensen Rank ligand-binding polypeptides
AU2002231602A1 (en) * 2001-02-09 2002-08-28 Maxygen Holdings Ltd. Rank ligand-binding polypeptides
PT1757619E (en) * 2001-04-03 2010-03-25 Nestle Sa Osteoprotegerin in milk
US7198798B2 (en) * 2001-05-10 2007-04-03 University Of Washington Methods and devices for promoting endothelial morphogenesis
WO2002098362A2 (en) * 2001-06-06 2002-12-12 Immunex Corporation Use of rank antagonists to treat cancer
MXPA04000134A (en) * 2001-06-26 2005-06-06 Abgenix Inc Antibodies to opgl.
EP1270015A3 (en) * 2001-06-29 2004-02-25 Sankyo Company Limited A complex comprising OCIF and Polysaccharide
US20030045942A1 (en) * 2001-09-05 2003-03-06 Lai Wen-Fu T. Regenerative bone implants
US20040157771A1 (en) * 2002-02-28 2004-08-12 Bird Timothy A. Rank-ligand-induced sodium/proton antiporter polypeptides
WO2003074084A1 (en) * 2002-03-01 2003-09-12 Sankyo Company, Limited A pharmaceutical composition
AU2003220529B2 (en) 2002-03-27 2006-09-07 Immunex Corporation Methods for increasing polypeptide production
AU2003243139B2 (en) * 2002-04-05 2007-06-21 Amgen Inc. Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
US20080249068A1 (en) * 2002-09-05 2008-10-09 Deluca Hector F Method of Extending the Dose Range of Vitamin D Compounds
US7259143B2 (en) * 2002-09-05 2007-08-21 Wisconsin Alumni Research Foundation Method of extending the dose range of vitamin D compounds
NZ554390A (en) 2004-12-13 2010-07-30 Cephalon Australia Vic Pty Ltd Osteoprotegerin variant proteins
US8137664B2 (en) * 2005-02-02 2012-03-20 Sdgi Holdings, Inc. Method and kit for repairing a defect in bone
US7982016B2 (en) 2007-09-10 2011-07-19 Amgen Inc. Antigen binding proteins capable of binding thymic stromal lymphopoietin
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
WO2012019160A1 (en) 2010-08-05 2012-02-09 Amgen Inc. Dipeptides to enhance yield and viability from cell cultures
WO2012145682A1 (en) 2011-04-21 2012-10-26 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
CN103827292B (en) 2011-07-01 2018-01-26 安姆根有限公司 Mammaliancellculture
CA2840637A1 (en) 2011-09-02 2013-03-07 Amgen Inc. Pharmaceutical product and method of analysing light exposure of a pharmaceutical product
GB201118840D0 (en) 2011-11-01 2011-12-14 Univ Sheffield Pulmonary hypertension II
AR089231A1 (en) 2011-12-15 2014-08-06 Amgen Inc FLOCULATION METHOD
GB2513024B (en) 2012-02-27 2016-08-31 Cellular Res Inc A clonal amplification method
WO2014109858A1 (en) 2013-01-14 2014-07-17 Amgen Inc. Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
TWI832345B (en) 2013-03-14 2024-02-11 美商安美基公司 Methods for increasing mannose content of recombinant proteins
SI2969099T2 (en) 2013-03-14 2022-04-29 Amgen Inc. Removal of leaked affinity purification ligand
US9481901B2 (en) 2013-05-30 2016-11-01 Amgen Inc. Methods for increasing mannose content of recombinant proteins
GB2525104B (en) 2013-08-28 2016-09-28 Cellular Res Inc Massively Parallel Single Cell Nucleic Acid Analysis
EP3063287A1 (en) 2013-10-31 2016-09-07 Amgen Inc. Use of monensin to regulate glycosylation of recombinant proteins
EP3094735A1 (en) 2014-01-13 2016-11-23 Amgen Inc. Regulating ornithine metabolism to manipulate the high mannose glycoform content of recombinant proteins
KR102519540B1 (en) 2014-01-29 2023-04-10 암젠 인크 Overexpression of n-glycosylation pathway regulators to modulate glycosylation of recombinant proteins
US10106829B2 (en) 2014-01-29 2018-10-23 Amgen Inc. Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins
US10189887B2 (en) * 2014-04-17 2019-01-29 Inserm (Institut National De La Sante Et De La Recherche Medicale) Polypeptides and uses thereof for reducing CD95-mediated cell motility
PL3152317T3 (en) 2014-06-04 2019-08-30 Amgen Inc. Methods for harvesting mammalian cell cultures
US11275090B2 (en) 2014-11-19 2022-03-15 Amgen Inc. Quantitation of glycan moiety in recombinant glycoproteins
CA2969225C (en) 2014-12-01 2023-08-22 Amgen Inc. Process for manipulating the level of glycan content of a glycoprotein
EP3259371B1 (en) 2015-02-19 2020-09-02 Becton, Dickinson and Company High-throughput single-cell analysis combining proteomic and genomic information
WO2016138496A1 (en) 2015-02-27 2016-09-01 Cellular Research, Inc. Spatially addressable molecular barcoding
US11535882B2 (en) 2015-03-30 2022-12-27 Becton, Dickinson And Company Methods and compositions for combinatorial barcoding
WO2016172373A1 (en) 2015-04-23 2016-10-27 Cellular Research, Inc. Methods and compositions for whole transcriptome amplification
US11124823B2 (en) 2015-06-01 2021-09-21 Becton, Dickinson And Company Methods for RNA quantification
EP3347465B1 (en) 2015-09-11 2019-06-26 Cellular Research, Inc. Methods and compositions for nucleic acid library normalization
US10301677B2 (en) 2016-05-25 2019-05-28 Cellular Research, Inc. Normalization of nucleic acid libraries
US10202641B2 (en) 2016-05-31 2019-02-12 Cellular Research, Inc. Error correction in amplification of samples
US10640763B2 (en) 2016-05-31 2020-05-05 Cellular Research, Inc. Molecular indexing of internal sequences
CA3034924A1 (en) 2016-09-26 2018-03-29 Cellular Research, Inc. Measurement of protein expression using reagents with barcoded oligonucleotide sequences
WO2018132610A1 (en) 2017-01-13 2018-07-19 Cellular Research, Inc. Hydrophilic coating of fluidic channels
US11680101B2 (en) 2017-01-27 2023-06-20 Kymab Limited Anti-OPG antibodies
US11319583B2 (en) 2017-02-01 2022-05-03 Becton, Dickinson And Company Selective amplification using blocking oligonucleotides
AU2018281745B2 (en) 2017-06-05 2022-05-19 Becton, Dickinson And Company Sample indexing for single cells
CA3099163A1 (en) 2018-05-01 2019-11-07 Amgen Inc. Antibodies with modulated glycan profiles
US11773441B2 (en) 2018-05-03 2023-10-03 Becton, Dickinson And Company High throughput multiomics sample analysis
WO2019213237A1 (en) 2018-05-03 2019-11-07 Becton, Dickinson And Company Molecular barcoding on opposite transcript ends
WO2020072380A1 (en) 2018-10-01 2020-04-09 Cellular Research, Inc. Determining 5' transcript sequences
US11932849B2 (en) 2018-11-08 2024-03-19 Becton, Dickinson And Company Whole transcriptome analysis of single cells using random priming
CN113195717A (en) 2018-12-13 2021-07-30 贝克顿迪金森公司 Selective extension in single cell whole transcriptome analysis
US11371076B2 (en) 2019-01-16 2022-06-28 Becton, Dickinson And Company Polymerase chain reaction normalization through primer titration
ES2945227T3 (en) 2019-01-23 2023-06-29 Becton Dickinson Co Antibody Associated Oligonucleotides
US12071617B2 (en) 2019-02-14 2024-08-27 Becton, Dickinson And Company Hybrid targeted and whole transcriptome amplification
CN114051534A (en) 2019-07-22 2022-02-15 贝克顿迪金森公司 Single cell chromatin immunoprecipitation sequencing assay
JP7522189B2 (en) 2019-11-08 2024-07-24 ベクトン・ディキンソン・アンド・カンパニー Use of Random Priming to Obtain Full-Length V(D)J Information for Immune Repertoire Sequencing
EP4090763A1 (en) 2020-01-13 2022-11-23 Becton Dickinson and Company Methods and compositions for quantitation of proteins and rna
EP4150118A1 (en) 2020-05-14 2023-03-22 Becton Dickinson and Company Primers for immune repertoire profiling
US11932901B2 (en) 2020-07-13 2024-03-19 Becton, Dickinson And Company Target enrichment using nucleic acid probes for scRNAseq
EP4247967A1 (en) 2020-11-20 2023-09-27 Becton, Dickinson and Company Profiling of highly expressed and lowly expressed proteins
KR20240128067A (en) 2021-12-29 2024-08-23 브리스톨-마이어스 스큅 컴퍼니 Generation of landing pad cell lines

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4870009A (en) * 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4873316A (en) * 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
FR2640537B1 (en) 1988-12-21 1992-02-21 Levy Guy INSTALLATION AND METHOD USING THE LASER EFFECT FOR CUTTING OR VAPORIZING VARIOUS MATERIALS AND FABRICS
US5585479A (en) * 1992-07-24 1996-12-17 The United States Of America As Represented By The Secretary Of The Navy Antisense oligonucleotides directed against human ELAM-I RNA
US5968817A (en) * 1993-03-15 1999-10-19 The Scripps Research Institute DNA encoding serotonin receptors
JP3284481B2 (en) 1993-08-20 2002-05-20 本田技研工業株式会社 Hydraulic control circuit of hydraulically operated transmission for vehicle
US6268212B1 (en) 1993-10-18 2001-07-31 Amgen Inc. Tissue specific transgene expression
JP3433495B2 (en) 1993-12-30 2003-08-04 カシオ計算機株式会社 Display control device and display control method
WO1996028546A1 (en) 1995-03-15 1996-09-19 Human Genome Sciences, Inc. Human tumor necrosis factor receptor

Also Published As

Publication number Publication date
US6613544B1 (en) 2003-09-02
US6284485B1 (en) 2001-09-04
US6288032B1 (en) 2001-09-11
US6284728B1 (en) 2001-09-04
IL205233A0 (en) 2011-01-31
DE69637695D1 (en) 2008-11-13
US6284740B1 (en) 2001-09-04
US6015938A (en) 2000-01-18

Similar Documents

Publication Publication Date Title
ZA9610770B (en) Osteoprotegerin.
GB2312899B (en) Osteoprotegerin
ZA967315B (en) Biphenylamides.
MX213417B (en) Phenylpyridazinones.
ZA9610858B (en) Heteroclyclic compounds.
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
ZA961955B (en) Indazolecarboxamides.
ZA968108B (en) Snack.
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA969625B (en) 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols
ZA966399B (en) Endothelin-receptor-antagonists.
ZA967087B (en) Solid sucralose.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
ZA964560B (en) Anit-viral compounds.
ZA976022B (en) Cycloalkano-pyridines.
ZA966750B (en) Halogenobenzimidazoles.
ZA966933B (en) Endothelin-receptor-antagonists.
ZA971466B (en) Endothelin-receptor-antagonists.
ZA967314B (en) Carbamoylcarboxamides.
ZA966699B (en) Substituted 2-phenylpyridines.
ZA969560B (en) Substituted 1-methyl-3-phenylpyrazoles.
ZA964264B (en) Retinoid-like compounds.
ZA971474B (en) Endothelin-receptor-antagonists.